Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Medtecs International Corporation Ltd. ( (SG:546) ).
Medtecs International Corporation Limited has announced boardroom changes, appointing Wang Bo-Shing Jim as an independent director effective 12 February 2026. Wang will also serve as chairman of the remuneration committee and sit on both the audit and nominating committees, and is deemed independent under Singapore’s Catalist rules. The move coincides with the resignation of independent director Nieh Chien-Chung, who is stepping down from the board and relinquishing his roles on the same committees. Following these changes, Medtecs has reshaped its board and audit committee composition, signalling a continued emphasis on independent oversight and corporate governance in line with SGX requirements.
More about Medtecs International Corporation Ltd.
Medtecs International Corporation Limited is a Bermuda-incorporated company listed on the Singapore Exchange’s Catalist board. The company operates in the healthcare and medical supplies sector, with a focus that necessitates adherence to SGX corporate governance and board independence requirements.
Average Trading Volume: 1,090,007
Technical Sentiment Signal: Sell
Current Market Cap: S$65.57M
For an in-depth examination of 546 stock, go to TipRanks’ Overview page.